Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill to regulate dietary supplements with streamlined approval processes for industry innovation.
The problem
Current dietary supplement regulations may slow innovation and market entry for new products. Industry seeks clearer pathways for product development and approval.
The proposal
Establishes new procedures for dietary supplement approval, potentially expediting product review and reducing regulatory barriers for manufacturers.
The impact
Affects dietary supplement manufacturers, consumers, and regulators. Companies may bring products faster to market. Consumers may access new products sooner.
Streamlined approval processes could allow companies to develop and release new dietary supplements more quickly. This may increase competition and give consumers more choices in the supplement market.
Reduced regulatory burden could help supplement companies grow and create jobs. Smaller businesses might find it easier to enter the market.
Faster approval processes mean consumers could access new supplement products sooner. This could provide more options for people seeking health alternatives.
Streamlined processes may help U.S. supplement makers compete globally with fewer restrictions than international competitors face.
Faster approval processes might reduce safety testing and oversight of new products. Consumers could be exposed to poorly tested supplements with unknown side effects.
Streamlined regulations could mean less monitoring of supplement effectiveness and quality. Companies might make misleading health claims without strong enforcement.
Reduced regulatory requirements may limit protections for consumers against contaminated or ineffective products. Vulnerable populations could be most affected.
With fewer regulations, dangerous or ineffective supplements could reach the market. Public health agencies would have harder time tracking adverse effects.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.